New collaborations make pharmacogenomics a SNP
- PMID: 10377514
- DOI: 10.1016/s1357-4310(99)01503-8
New collaborations make pharmacogenomics a SNP
Similar articles
-
Pharmacogenetics, pharmacogenomics, and cardiovascular therapeutics: the way forward.Am J Cardiovasc Drugs. 2002;2(5):287-96. doi: 10.2165/00129784-200202050-00001. Am J Cardiovasc Drugs. 2002. PMID: 14727958 Review.
-
[Pharmacogenomics of cardiovascular pharmacology].Nihon Yakurigaku Zasshi. 2006 Sep;128(3):130-2. doi: 10.1254/fpj.128.130. Nihon Yakurigaku Zasshi. 2006. PMID: 16971774 Review. Japanese. No abstract available.
-
Cardiovascular Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics for the Clinical Practitioner.J Cardiovasc Pharmacol Ther. 2016 Jan;21(1):20-6. doi: 10.1177/1074248415590196. Epub 2015 Jun 8. J Cardiovasc Pharmacol Ther. 2016. PMID: 26054891 Review.
-
Pharmacogenetics in cardiovascular diseases: State of the art and implementation-recommendations of the French National Network of Pharmacogenetics (RNPGx).Therapie. 2017 Apr;72(2):257-267. doi: 10.1016/j.therap.2016.09.017. Epub 2017 Jan 30. Therapie. 2017. PMID: 28237404 Review.
-
Pharmacogenomics in cardiovascular diseases.Prog Cardiovasc Dis. 2002 May-Jun;44(6):479-98. doi: 10.1053/pcad.2002.123467. Prog Cardiovasc Dis. 2002. PMID: 12077721 Review.
Cited by
-
Mining of haplotype-based expressed sequence tag single nucleotide polymorphisms in citrus.BMC Genomics. 2013 Nov 1;14:746. doi: 10.1186/1471-2164-14-746. BMC Genomics. 2013. PMID: 24175923 Free PMC article.
-
Pharmacogenetics and pharmacogenomics: recent developments, their clinical relevance and some ethical, social, and legal implications.J Mol Med (Berl). 2003 Mar;81(3):135-40. doi: 10.1007/s00109-002-0415-6. J Mol Med (Berl). 2003. PMID: 12755119
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical